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Cytogenetically normal acute myeloid leukemia (CN-AML) compose between 40%
and 50% of all adult acute myeloid leukemia (AML) cases. In this clinically diverse
group, molecular aberrations, such as FLT3-ITD, NPM1, and CEBPA mutations,
recently have added to the prognostic accuracy. Aberrant DNA methylation is a
hallmark of cancer, including AML. We investigated in total 118 CN-AML samples in
a test and a validation cohort for genome-wide promoter DNA methylation with
Illumina Methylation Bead arrays and compared them with normal myeloid
precursors and global gene expression. IDH and NPM1 mutations were associated
with different methylation patterns (P = .0004 and .04, respectively). Genome-wide
methylation levels were elevated in IDH-mutated samples (P = .006). We observed a
negative impact of DNA methylation on transcription. Genes targeted by Polycomb
group (PcG) proteins and genes associated with bivalent histone marks in stem cells
showed increased aberrant methylation in AML (P < .0001). Furthermore, high
methylation levels of PcG target genes were independently associated with better
progression-free survival (odds ratio = 0.47, P = .01) and overall survival (odds ratio
= 0.36, P = .001). In summary, genome-wide methylation patterns show preferential
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